Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Alexander commented, "I have collaborated with Andrew for many years within clinical research to drive innovation on multiple occasions. When Andrew laid out the mission and objectives of Coronado Research, I was excited by the opportunity to join such a strong leadership team. Our objective is to revolutionize the clinical research process and challenge the status quo of how we bring drugs to market today. I am very much looking forward to working with the team to bring positive change to the industry." 

About Coronado Research 

Coronado Research is a consultancy-led, professional services organization, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimize the clinical development process by leveraging all the data available using AI, ML, and leading technologies. 

Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to "join-the-dots" between these disciplines to ensure treatments are developed with the end in mind and better match market needs. 

For further information please contact: [email protected] 

Website: www.coronado-research.com

View original content:https://www.prnewswire.co.uk/news-releases/coronado-research-limited-announce-the-appointment-of-alexander-mccormick-as-chief-commercial-officer-302305713.html